Characteristics of the Toxoplasma Hemagglutination Test Antigen
Open Access
- 1 February 1959
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 82 (2) , 146-150
- https://doi.org/10.4049/jimmunol.82.2.146
Abstract
Summary: Toxoplasma hemagglutination test antigen, which is a lysate of washed parasites, loses potency rapidly when stored in the liquid state. It is stable for long periods when kept frozen or when lyophilized or precipitated by acetone and dried from ether. The dry powders are stable at 37° C and 56° C for at least five months and one month respectively. Potency is lost on filtration through a No. 02 Selas candle. The antigen elicits a skin reaction in toxoplasmin-sensitive patients. It also produces antibodies demonstrable by dye test when injected into mice. The antigen appears to be mainly protein in nature, with a high concentration of ribonucleoprotein. Nitrogen content seems to be correlated with potency. The hemagglutination test has presented difficulties with small animal sera, but has given consistently good results with human sera. It lags about four days behind the dye test in the demonstration of antibodies in early cases of human toxoplasmosis, but agrees very well with the dye test in late stages of the infection. The test has been performed satisfactorily with red blood cells of sheep or of “O” rH negative humans, and with formalinized cells.Keywords
This publication has 4 references indexed in Scilit:
- A Comparison of Results of Hemagglutination and Dye Tests for Toxoplasmosis in a Survey of Trinidad NativesThe American Journal of Tropical Medicine and Hygiene, 1958
- A Hemagglutination Test for ToxoplasmosisJournal of Parasitology, 1957
- STUDIES ON HEMAGGLUTINATION INHIBITION PHENOMENA .1. THE PRESENCE OF INHIBITING ANTIGEN IN TYPHUS-INFECTED ANIMALS1955
- MICROMETHODS FOR THE STUDY OF PROTEINS AND ANTIBODIES .1. PROCEDURE AND GENERAL APPLICATIONS OF HEMAGGLUTINATION AND HEMAGGLUTINATION-INHIBITION REACTIONS WITH TANNIC ACID AND PROTEIN-TREATED RED BLOOD CELLS1954